Drug Search Results
More Filters [+]

LNF-2008

Alternative Names: LNF-2008, LNF 2008, LNF2008
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Antibody

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Shandong New Era Pharmaceutical Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for LNF-2008

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Oncology Solid Tumor Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20242433

P1

Unknown

Oncology Solid Tumor Unspecified

None

Recent News Events

Date

Type

Title